• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Wed, 24.04.24

CORONAVIRUS (COVID-19)

IMAJ | volume 24

Journal 7, July 2022
pages: 441-443

Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients

1Department of Pulmonary Medicine, Meir Medical Center, Kfar Saba, Israel 2Department of Clinical Development, Kamada Ltd, Rehovot, Israel 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Summary

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel